Advanced Medical Solutions Grp PLC
14 March 2001
Advanced Medical Solutions Group plc Announce Collaboration with
Johnson & Johnson Consumer Products Company
Winsford: Wednesday 14 March, 2001 Advanced Medical Solutions Group plc
announced today they had entered into a collaboration with Johnson & Johnson
Consumer Products Company to supply a patented Calcium Alginate based material
for inclusion in certain products for the US and Canadian consumer market.
Commenting on the collaboration Don Evans (Chief Executive) said:
'We are extremely pleased to be working with as strong a partner as Johnson &
Johnson Consumer Products Company and this collaboration further enhances our
position in the important American consumer products market. We are committed
to launching innovative new products and this collaboration enables us to
bring further enhanced value products into the market.'
For press enquiries please contact:
Advanced Medical Solutions Group plc Tel : 01606 863500
Don Evans, Chief Executive
Graeme Brookes, Sales & Marketing Director
Mary Tavener, Finance Director
www.admedsol.com
Gavin Anderson & Company Tel : 0207 457 2345
Philip Ward / Charlotte Stone
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.